Search Results - "Niethammer, A. G."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    DNA vaccines designed to inhibit tumor growth by suppression of angiogenesis by Reisfeld, Ralph A, Niethammer, A G, Luo, Y, Xiang, R

    “…The development of new blood vessels, i.e. angiogenesis, is a rate-limiting step in the development of tumors since tumor growth is generally limited to 1-2…”
    Get more information
    Journal Article
  2. 2

    MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma by RUEHLMANN, J. Michael, RONG XIANG, NIETHAMMER, Andreas G, YI BA, PERTL, Ursula, DOLMAN, Carrie S, GILLIES, Stephen D, REISFELD, Ralph A

    Published in Cancer research (Chicago, Ill.) (01-12-2001)
    “…The induction of a CTL response capable of eradicating disseminated tumor metastases and the establishment of a persistent tumor-protective immunity remain…”
    Get full text
    Journal Article
  3. 3

    Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma by NIETHAMMER, Andreas G, RONG XIANG, RUEHLMANN, J. Michael, LODE, Holger N, DOLMAN, Carrie S, GILLIES, Stephen D, REISFELD, Ralph A

    Published in Cancer research (Chicago, Ill.) (15-08-2001)
    “…We demonstrate that a mouse-human chimeric anti-ganglioside GD2-interleukin (IL)-2 fusion protein (ch14.18-IL2) substantially amplifies tumor-protective…”
    Get full text
    Journal Article
  4. 4

    A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth by Niethammer, A G, Xiang, R, Becker, J C, Wodrich, H, Pertl, U, Karsten, G, Eliceiri, B P, Reisfeld, R A

    Published in Nature medicine (01-12-2002)
    “…Tumor cells are elusive targets for immunotherapy due to their heterogeneity and genetic instability. Here we describe a novel, oral DNA vaccine that targets…”
    Get full text
    Journal Article
  5. 5

    Potential target antigens for immunotherapy in human pancreatic cancer by Schmitz-Winnenthal, F.H, Galindo-Escobedo, L.V, Rimoldi, D, Geng, W, Romero, P, Koch, M, Weitz, J, Krempien, R, Niethammer, A.G, Beckhove, P, Buchler, M.W, Z’graggen, K

    Published in Cancer letters (18-07-2007)
    “…Abstract Background To be effective and selective, immunotherapy ideally targets specifically tumor cells and spares normal tissues. Identification of tumor…”
    Get full text
    Journal Article
  6. 6

    Use of the platelet histogram maximum in evaluating thrombocytopenia by Niethammer, Andreas G., Forman, Edwin N.

    Published in American journal of hematology (01-01-1999)
    “…The purpose of this study was to compare the mean platelet volume (MPV) and the highest peak of the platelet volume distribution curve (maximum of the platelet…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy by Niethammer, Andreas G, Wodrich, Harald, Loeffler, Markus, Lode, Holger N, Emmerich, Kathrin, Abdollahi, Amir, Krempien, Robert, Debus, Juergen, Huber, Peter E, Reisfeld, Ralph A

    Published in The FASEB journal (01-01-2005)
    “…ABSTRACT Acquired multidrug resistance (MDR) remains a major challenge in the treatment of cancer with chemotherapeutic drugs. It can be mediated by the…”
    Get full text
    Journal Article
  9. 9

    An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice by Niethammer, Andreas G, Primus, F.James, Xiang, Rong, Dolman, Carrie S, Ruehlmann, J.Michael, Ba, Yi, Gillies, Stephen D, Reisfeld, Ralph A

    Published in Vaccine (12-11-2001)
    “…A DNA vaccine encoding human carcinoembryonic antigen (CEA) broke peripheral T-cell tolerance toward this tumor self-antigen expressed by Lewis lung carcinoma…”
    Get full text
    Journal Article
  10. 10

    Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice by RONG XIANG, SILLETTI, Steve, LODE, Holger N, DOLMAN, Carrie S, RUEHLMANN, J. Michael, NIETHAMMER, Andreas G, PERTL, Ursula, GILLIES, Stephen D, PRIMUS, F. James, REISFELD, Ralph A

    Published in Clinical cancer research (01-03-2001)
    “…Peripheral T-cell tolerance toward human carcinoembryonic self-antigen (CEA) was broken in CEA-transgenic C57BL/6J mice by an oral CEA-based DNA vaccine. This…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis by Hauer, Arnaud D, van Puijvelde, Gijs H.M, Peterse, Niels, de Vos, Paula, van Weel, Vincent, van Wanrooij, Eva J.A, Biessen, Erik A.L, Quax, Paul H.A, Niethammer, Andreas G, Reisfeld, Ralph A, van Berkel, Theo J.C, Kuiper, Johan

    “…OBJECTIVE—Vascular endothelial growth factor receptor 2 (VEGFR2)–overexpressing cells may form an interesting target for the treatment of atherosclerosis…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis by Reisfeld, Ralph A., Niethammer, Andreas G., Luo, Yunping, Xiang, Rong

    Published in Immunological reviews (01-06-2004)
    “…Four novel oral DNA vaccines provide long‐lived protection against melanoma, colon, breast, and non‐small cell lung carcinoma in mouse model systems. The…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Bisphosphonates and bone metastases: current status and future directions by Krempien, Robert, Niethammer, Andreas, Harms, Wolfgang, Debus, Jürgen

    Published in Expert review of anticancer therapy (01-04-2005)
    “…Since bone metastases in advanced cancer are common and frequently lead to skeletal-related morbid complications, their treatment remains a major challenge in…”
    Get full text
    Journal Article